Skip to main content
. 2023 Mar 15;110(9):1080–1083. doi: 10.1093/bjs/znad066

Fig. 1.

Fig. 1

Outcome for all 73 patients with appropriate ex vivo data

a Peritoneal recurrence-free survival for the sensitive and resistant groups (log-rank test P = 0.007). b Overall survival for the sensitive and resistant groups (log-rank test; P = 0.397).